Benzinga's M&A Chatter for Monday November 23, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday November 23, 2015: Diebold Offers to Acquire Wincor Nixdorf for €38.98/Share in Cash Plus 0.434 Deibold Shares The Deal:
Diebold, Incorporated DBD and Wincor Nixdorf AG WNXDF announced Monday, that Diebold will launch a voluntary public tender offer to all shareholders of Wincor Nixdorf. Under the terms of the agreement, Diebold will offer Wincor Nixdorf shareholders €38.98 in cash plus 0.434 Diebold common shares per Wincor Nixdorf share, valuing Wincor Nixdorf at approximately $1.8 billion, including debt. Diebold shares fell 6.69% Monday, closing at $35.00. Comtech Reports to Acquire TeleComm Systems for $5.00/Share in Cash The Deal:
Comtech Telecommunications Corp. CMTL and TeleCommunication Systems, Inc. TSYS announced Monday a definitive merger agreement under which Comtech will acquire TCS for $5.00 per share in cash via a tender offer, for an enterprise value of approximately a $430.8 million. The deal is expected to close no later than March 2016. TeleCommunication Systems rose 12.5% Monday, closing at $4.94. Pfizer to Acquire Allergan in $150B Deal The Deal:
Pfizer Inc. PFE and Allergan plc AGN announced Monday, that the companies have entered into, a definitive merger agreement under which Pfizer will merge with Allergan in a stock transaction valued at $363.63 per Allergan share, for a total enterprise value of approximately $160 billion. Under the agreement, Allergan shareholders will receive 11.3 shares of the combined company for each Allergan shares, while Pfizer shareholders will receive one share of the combined company for each Pfizer share. The transaction is expected to be completed in H2 of 2016. Allergan fell 3.5% Monday, closing at $301.72. Pfizer fell 2.64% to close at $31.33.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsRumorsM&AMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!